DEVELOPMENT OF A PLATFORM FOR MUTANOMA IDENTIFICATION AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRECIVAX (Q4781965)
Jump to navigation
Jump to search
Project Q4781965 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DEVELOPMENT OF A PLATFORM FOR MUTANOMA IDENTIFICATION AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRECIVAX |
Project Q4781965 in Italy |
Statements
964,438.69 Euro
0 references
1,329,656.75 Euro
0 references
72.53 percent
0 references
1 November 2016
0 references
31 December 2018
0 references
NOUSCOM SOCIETA' A RESPONSABILITA' LIMITATA
0 references
BIOTECNOLOGIE (Italian)
0 references
БИОТЕХНОЛОГИЯ (Bulgarian)
0 references
BIOTECHNOLOGIE (Czech)
0 references
BIOTEKNOLOGI (Danish)
0 references
BIOTECHNOLOGIE (German)
0 references
ΒΙΟΤΕΧΝΟΛΟΓΊΑ (Greek)
0 references
BIOTECNOLOGÍA (Spanish)
0 references
BIOTEHNOLOOGIA (Estonian)
0 references
BIOTEKNIIKKA (Finnish)
0 references
BIOTECHNOLOGIE (French)
0 references
BITEICNEOLAÍOCHT (Irish)
0 references
BIOTEHNOLOGIJA (Croatian)
0 references
BIOTECHNOLÓGIA (Hungarian)
0 references
BIOTECHNOLOGIJOS (Lithuanian)
0 references
BIOTEHNOLOĢIJA (Latvian)
0 references
BIJOTEKNOLOĠIJA (Maltese)
0 references
BIOTECHNOLOGIE (Dutch)
0 references
BIOTECNOLOGIA (Portuguese)
0 references
BIOTEHNOLOGIE (Romanian)
0 references
BIOTECHNOLÓGIA (Slovak)
0 references
BIOTEHNOLOGIJA (Slovenian)
0 references
BIOTEKNIK (Swedish)
0 references
NAPOLI
0 references
ROMA
0 references
10 April 2023
0 references